SMMT - Summit Therapeutics Inc.
26.38
1.260 4.776%
Share volume: 10,182,255
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$25.12
1.26
0.05%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-24-2025 | 05-01-2025 | 10-20-2025 | 02-23-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | ||||
| Operating expenses | 65.819 M | 66.851 M | 234.211 M | 224.925 M | |
| Selling general and admin | 14.437 M | 15.586 M | 103.115 M | 77.633 M | |
| Research and development | 51.382 M | 51.265 M | 131.096 M | 147.292 M | |
| Total expenses | 65.614 M | 66.851 M | 234.211 M | 224.925 M | |
| 1.89% | 250.35% | -3.96% | |||
| Operating income | -65.614 M | -66.851 M | -234.211 M | -224.925 M | |
| Ebit | -65.614 M | -62.913 M | -234.211 M | -224.925 M | |
| Pretax income | -74.572 M | -62.913 M | -234.211 M | -214.025 M | |
| -15.63% | 272.28% | -8.62% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -61.203 M | -62.913 M | -231.793 M | -219.172 M | |
| -2.79% | -268.43% | 5.44% |